Jump to content

Page values for "Nortriptyline"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringNortriptyline (hydrochloride)
brandStringPamelor (US brand discontinued; generic widely available), Aventyl
structureFile
classesList of String, delimiter: ,[[:Category:Tricyclic antidepressants|Tricyclic antidepressant (TCA secondary amine)]] [[:Category:Antidepressants|Antidepressant]] [[:Category:Neuropathic pain medicines|Neuropathic pain medicine]] [[:Category:Migraine prophylactics|Migraine prophylactic]]
mechanismString'"`UNIQ--vote-00000019-QINU`"' Therapeutic plasma-level monitoring is standard practice for TCAs given the narrow therapeutic index and the established plasma-level-efficacy correlation. CYP2D6 substrate; CPIC PGx guidance applies for dose individualization'"`UNIQ--ref-0000001A-QINU`"'.
usesString'"`UNIQ--vote-0000001B-QINU`"', '"`UNIQ--vote-0000001C-QINU`"', '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"'
starting_doseStringDepression: 25 mg PO TID-QID or 75 mg at bedtime, titrate to 75-150 mg/day. Neuropathic pain: 10-25 mg at bedtime, titrate to 50-100 mg/day. Elderly: 10 mg at bedtime (Beers-list cautions, though less than amitriptyline)
preparationsStringCapsules 10, 25, 50, 75 mg; oral solution 10 mg/5 mL
fda_maxString150 mg/day; therapeutic plasma-level monitoring recommended (target 50-150 ng/mL window)
pill_idText
routesList of String, delimiter: ,Oral
onsetStringPain and migraine prophylaxis effect 1-4 weeks; antidepressant effect 4-6 weeks
durationString24 hours (HS dosing)
halflifeString18-44 hours'"`UNIQ--ref-00000020-QINU`"'
bioavailabilityString~50% (oral)'"`UNIQ--ref-00000021-QINU`"'
pregnancyStringTCA class signal; limited human data specific to nortriptyline.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults'"`UNIQ--ref-00000022-QINU`"'